D-0498-2024 Class II Ongoing
FDA drug recall D-0498-2024 was initiated by MACLEODS PHARMA USA, INC on May 7, 2024 and is designated Class II. Reason for recall: Presence of foreign substance: plastic-like substance. The recall status is ongoing. Affected quantity: 1,048 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 22, 2024
- Initiation Date
- May 7, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,048 bottles
Product description
Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44
Reason for recall
Presence of foreign substance: plastic-like substance.
Distribution pattern
USA Nationwide
Code information
Lot #: BLK2304A, Exp. 07/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0498-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026